Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sébastien Combes

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Experimental Hematology|October 17, 2008
4-arylcoumarin analogues of combretastatins stimulate apoptosis of leukemic cells from chronic lymphocytic leukemia patientsChristian Billard, Faouzia Menasria, Claire Quiney, et al.
Chemico-Biological Interactions|November 29, 2025
Alkyne modification of DNA cross-linking antitumor agent SJG-136 to monitor induced lesions in cells by click chemistrySara Berrada, Violette Azzoni, Gilles Audoly, et al.
European Journal of Medicinal Chemistry|November 17, 2009
Synthesis and antiprotozoal activity of 4-arylcoumarinsJean-Thomas Pierson, Aurélien Dumètre, Sébastien Hutter, et al.
Journal of Medicinal Chemistry|December 3, 2003
Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatinsChristian Bailly, Christine Bal, Pascale Barbier, et al.
RSC Medicinal Chemistry|January 22, 2021
Allocolchicinoids bearing a Michael acceptor fragment for possible irreversible binding of tubulinEkaterina S Sazanova, Iuliia A Gracheva, Diane Allegro, et al.
Journal of Medicinal Chemistry|May 8, 2014
New Ianthelliformisamine derivatives as antibiotic enhancers against resistant Gram-negative bacteriaCyril Pieri, Diane Borselli, Carole Di Giorgio, et al.
Biochemistry|July 27, 2006
Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulinCatherine Rappl, Pascale Barbier, Véronique Bourgarel-Rey, et al.
Plos One|October 3, 2012
Tumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancerLynda Mezil, Carole Berruyer-Pouyet, Olivier Cabaud, et al.
Bioorganic & Medicinal Chemistry|September 23, 2008
Synthesis and biological evaluation of polymethoxylated 4-heteroarylcoumarins as tubulin assembly inhibitorOlga G Ganina, Etienne Daras, Véronique Bourgarel-Rey, et al.
Journal of Medicinal Chemistry|April 15, 2011
Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins. Part 2Sébastien Combes, Pascale Barbier, Soazig Douillard, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Experimental Hematology|October 17, 2008
4-arylcoumarin analogues of combretastatins stimulate apoptosis of leukemic cells from chronic lymphocytic leukemia patientsChristian Billard, Faouzia Menasria, Claire Quiney, et al.
Chemico-Biological Interactions|November 29, 2025
Alkyne modification of DNA cross-linking antitumor agent SJG-136 to monitor induced lesions in cells by click chemistrySara Berrada, Violette Azzoni, Gilles Audoly, et al.
European Journal of Medicinal Chemistry|November 17, 2009
Synthesis and antiprotozoal activity of 4-arylcoumarinsJean-Thomas Pierson, Aurélien Dumètre, Sébastien Hutter, et al.
Journal of Medicinal Chemistry|December 3, 2003
Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatinsChristian Bailly, Christine Bal, Pascale Barbier, et al.
RSC Medicinal Chemistry|January 22, 2021
Allocolchicinoids bearing a Michael acceptor fragment for possible irreversible binding of tubulinEkaterina S Sazanova, Iuliia A Gracheva, Diane Allegro, et al.
Journal of Medicinal Chemistry|May 8, 2014
New Ianthelliformisamine derivatives as antibiotic enhancers against resistant Gram-negative bacteriaCyril Pieri, Diane Borselli, Carole Di Giorgio, et al.
Biochemistry|July 27, 2006
Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulinCatherine Rappl, Pascale Barbier, Véronique Bourgarel-Rey, et al.
Plos One|October 3, 2012
Tumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancerLynda Mezil, Carole Berruyer-Pouyet, Olivier Cabaud, et al.
Bioorganic & Medicinal Chemistry|September 23, 2008
Synthesis and biological evaluation of polymethoxylated 4-heteroarylcoumarins as tubulin assembly inhibitorOlga G Ganina, Etienne Daras, Véronique Bourgarel-Rey, et al.
Journal of Medicinal Chemistry|April 15, 2011
Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins. Part 2Sébastien Combes, Pascale Barbier, Soazig Douillard, et al.
Pageof 2